Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis
Nicolini, Franck E., Masszi, Tamas, Shen, Zhixiang, Gallagher, Neil J., Jootar, Saengsuree, Powell, Bayard L., Dorlhiac-Llacer, Pedro Enrique, Zheng, Ming, Szczudlo, Tomasz, Turkina, AnnaТом:
53
Мова:
english
Журнал:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2011.627480
Date:
May, 2012
Файл:
PDF, 429 KB
english, 2012
File converter
Більше результатів пошуку
More benefits 
